LDGraft™
Lumbar Interbody Fusion (Degenerative Disc Disease)
Clinical TrialActive
Key Facts
Indication
Lumbar Interbody Fusion (Degenerative Disc Disease)
Phase
Clinical Trial
Status
Active
Company
About Locate Bio
Locate Bio is an innovative private biotech company building a diversified orthobiologics portfolio, with its lead candidate, LDGraft™, currently in clinical trials for spinal fusion. The company's strategy centers on developing biomimetic recombinant human BMP-2 (rhBMP-2) products and synthetic calcium phosphate scaffolds to dominate specific market segments in orthopedics and spine surgery. With a seasoned leadership team and an FDA Breakthrough Device designation for its lead program, Locate Bio is positioning itself as a future leader in the regenerative medicine space for musculoskeletal conditions.
View full company profile